Peer-reviewed veterinary case report
Additional treatments often needed with allergen immunotherapy
By Colombo, S et al.·Published in The Veterinary record·2007·Royal (Dick) School of Veterinary Studies, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy.
- Species:
- dog
Plain-English summary
A group of 27 dogs with atopic dermatitis (a skin allergy) undergoing allergen-specific immunotherapy (ASIT) often needed extra treatments to manage secondary infections and side effects. Most dogs, about 74%, developed bacterial skin infections, and 66.6% had yeast infections, which required additional medications. Some dogs also needed glucocorticoids to help with itching and other symptoms. A few experienced side effects from the ASIT and required antihistamines to continue their treatment. Overall, while ASIT can be effective, many dogs may need extra care to address these common issues.
People also search for: dog skin allergy treatment · atopic dermatitis in dogs · dog yeast infection treatment · glucocorticoids for itching in dogs · antihistamines for dog allergies
Abstract
Allergen-specific immunotherapy (ASIT) is one of the main treatments for atopic dermatitis in dogs, but it often requires additional treatments such as antibacterial and antifungal therapy for secondary bacterial and yeast infections, or antipruritic drugs to control the clinical signs or treat the adverse effects of the immunotherapy. Twenty-seven dogs enrolled in a study of ASIT were clinically assessed four times over a period of nine months; their requirement for treatment for secondary bacterial and yeast infections, for the administration of glucocorticoids as additional antipruritic therapy, and for the treatment of any adverse effects of the ASIT were evaluated. Twenty (74 per cent) of the dogs were treated for superficial bacterial pyoderma, 18 (66.6 per cent) required treatment for Malassezia species dermatitis on one or more occasions, eight (29.6 per cent) required treatment for otitis externa due to Malassezia species or bacteria, and eight required glucocorticoids to control their clinical signs. Five (18.5 per cent) of the dogs experienced adverse effects due to the ASIT and two required treatment with antihistamines (H1 receptor antagonists) in order to continue with the ASIT.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/17586789/